Friese, K., Marmé, F., & Heublein, S. (2018). The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer. Journal of cancer research and clinical oncology, 144(1), . https://doi.org/10.1007/s00432-017-2510-7
Chicago-Zitierstil (17. Ausg.)Friese, Klaus, Frederik Marmé, und Sabine Heublein. "The G Protein-coupled Estrogen Receptor (GPER/GPR30) May Serve as a Prognostic Marker in Early-stage Cervical Cancer." Journal of Cancer Research and Clinical Oncology 144, no. 1 (2018). https://doi.org/10.1007/s00432-017-2510-7.
MLA-Zitierstil (9. Ausg.)Friese, Klaus, et al. "The G Protein-coupled Estrogen Receptor (GPER/GPR30) May Serve as a Prognostic Marker in Early-stage Cervical Cancer." Journal of Cancer Research and Clinical Oncology, vol. 144, no. 1, 2018, https://doi.org/10.1007/s00432-017-2510-7.